NCCR Molecular Oncology (NCCR) is a cancer research organization, which was started by Swiss Institute for Experimental Cancer Research (ISREC) in collaboration with several partner institutes, such as the Ludwig Institute for Cancer Research and the Department of Biochemistry of the University of Lausanne. The company comprises eighteen cancer research projects and supports four related technology platforms. NCCR has collaborations between NCCR scientists at ISREC, the Ludwig Institute and the Department of Biochemistry, and clinical researchers and physicians in the University Hospitals of Lausanne (CHUV) and Geneva (HUG) and the Multidisciplinary Oncology Center in Lausanne (CePO). The company is headquartered in Lausanne, Switzerland.

Street: 
Rue du Bugnon 25
City: 
Lausanne
Postcode: 
CH - 1011
Federal State : 
Switzerland
WebSite: 
www.nccr-oncology.ch

Company Index Score

Current Index Score Historical Index Score
  • NCCR Molecular Oncology currently scores 50 % in the index.
  • NCCR Molecular Oncology is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • NCCR Molecular Oncology is currently ranked 2 out of 2588 companies. This is in the top 0.077 % percent of Construction companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets